Veerle Bossuyt
0000-0003-0403-6791
Publication & Citation Trends
Publications
0 total
Abstract 767: Genomics and transcriptomics profiling of BRCA mutation carriers revealed the landscape of early pathogenesis of BRCA1/2-associated breast cancer
Cited by 0
Semantic Scholar
Abstract 4353: Utilizing scRNA sequencing to understand biomarkers of response and resistance to Sacitizumab Govetican in localized TNBC
Cited by 1
Semantic Scholar
Selection biases in the systematic collection of breast biobank specimens.
Cited by 1
Semantic Scholar
Metaplastic Breast Cancer: A Review.
Cited by 44
Semantic Scholar
Abstract PD10-01: The PEARL trial: Pre-operative pembrolizumab with radiation therapy in early stage triple negative breast cancer
Cited by 6
Semantic Scholar
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression OA
Cited by 108
Semantic Scholar
Intra- and Interlaboratory Reproducibility of the Sensitivity to Endocrine Therapy Assay for Stage II/III Breast Cancer. OA
Cited by 5
Semantic Scholar
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group OA
Cited by 3
Semantic Scholar
Locally recurrent secretory carcinoma of the breast. OA
Cited by 9
Semantic Scholar
Research Topics
HER2/EGFR in Cancer Research
(49)
Cancer Immunotherapy and Biomarkers
(39)
Breast Cancer Treatment Studies
(32)
Breast Lesions and Carcinomas
(25)
Cancer Cells and Metastasis
(20)
Affiliations
Brigham and Women's Hospital
United States Food and Drug Administration
Yale New Haven Hospital
Los Alamos National Laboratory
Harvard University